Compound details
Phenylmethanethiol
| Compound ID | CDAMM00980 |
|---|---|
| Common name | Phenylmethanethiol | IUPAC name | phenylmethanethiol |
| Molecular formula | C7H8S |
| Retention time | 0.26 |
|---|---|
| Adduct | [2M+K]+ |
| Actual mz | 287.033 | Theoretical mz | 287.033 |
| Error | 1.25 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.0622 |
| Inchi key | UENWRTRMUIOCKN-UHFFFAOYSA-N |
|---|---|
| Smiles | SCC=1C=CC=CC1 |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q16853 | AOC3 | Amine oxidase, copper containing | T69619 | SEA |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SEA |
| P15144 | ANPEP | Aminopeptidase N | T67272 | SEA |
| P08473 | MME | Neprilysin | T05409 | SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SEA |
| Q05940 | SLC18A2 | Synaptic vesicular amine transporter (by homology) | T48873 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| P14902 | IDO1 | Indoleamine 2,3-dioxygenase | T89697 | SwissTargetPrediction and SEA |
| Q99685 | MGLL | Monoglyceride lipase | T18664 | SEA |
| P15085 | CPA1 | Carboxypeptidase A1 | T33966 | SEA |
| Q99571 | P2RX4 | P2X purinoceptor 4 | T60330 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T69619 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q16853 | AOC3 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T67272 | DI0351 | Psoriasis | [ICD-11: EA90] | P15144 | ANPEP |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T48873 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q05940 | SLC18A2 |
| T48873 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | Q05940 | SLC18A2 |
| T48873 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | Q05940 | SLC18A2 |
| T48873 | DI0137 | Essential hypertension | [ICD-11: BA00] | Q05940 | SLC18A2 |
| T48873 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q05940 | SLC18A2 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T89697 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14902 | IDO1 |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |